NanoViricides, Inc. (NNVC) DCF Valuation

NanoViricides, Inc. (NNVC) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

NanoViricides, Inc. (NNVC) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insights into your NanoViricides, Inc. (NNVC) valuation analysis with our cutting-edge DCF Calculator! This Excel template comes preloaded with real (NNVC) data, enabling you to adjust forecasts and assumptions for an accurate assessment of NanoViricides' intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -7.3 -8.0 -7.4 -7.8 -7.8 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .7 .7 .7 .7 .8 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -8.0 -8.7 -8.1 -8.6 -8.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 13.7 20.5 14.1 8.1 4.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .4 .2 .1 .2 .4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.2 -.3 -.2 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -8.0 -8.8 -8.1 -8.6 -8.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.9 -8.5 -7.8 -7.9 -7.7 -.4 .0 .0 .0 .0
WACC, % 9.02 9.02 9.02 9.02 9.02 9.02 9.02 9.02 9.02 9.02
PV UFCF
SUM PV UFCF -.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -5
Equity Value 4
Diluted Shares Outstanding, MM 12
Equity Value Per Share 0.38

What You Will Receive

  • Pre-Filled Financial Model: NanoViricides’ actual data facilitates accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates provide immediate results as you implement changes.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation.
  • Customizable and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasts.

Key Features

  • Comprehensive Data: NanoViricides, Inc.'s (NNVC) extensive historical financial records and pre-populated projections.
  • Customizable Parameters: Modify WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Insights: Instantly view the recalculated intrinsic value of NanoViricides, Inc. (NNVC).
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based NNVC DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional factors.
  3. Instant Calculations: The model automatically recalculates NanoViricides, Inc.’s intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the outcomes to inform your investment or financial evaluations.

Why Choose This Calculator for NanoViricides, Inc. (NNVC)?

  • Designed for Experts: A specialized tool utilized by researchers, financial analysts, and biotech consultants.
  • Accurate Data: NanoViricides' historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically calculates intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance helps you navigate the process with ease.

Who Should Use NanoViricides, Inc. (NNVC)?

  • Investors: Gain insights into cutting-edge antiviral therapies to make informed investment choices.
  • Healthcare Professionals: Utilize comprehensive data on nanomedicine for enhanced patient care strategies.
  • Researchers: Access innovative research tools and findings to support your studies in virology.
  • Pharmaceutical Companies: Explore collaboration opportunities and advancements in drug development.
  • Students and Educators: Leverage real-world case studies to enrich learning in biomedical fields.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled NanoViricides, Inc. (NNVC) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for NanoViricides, Inc. (NNVC).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.